Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. Market Characterisitics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Segmentation
4.6. Market Dynamics
4.6.1. Drivers
4.6.2. Restraints
4.6.3. Opportunities
4.7. DRO - Impact Analysis
5. Animal Type: Market Size & Analysis
5.1. Overview
5.2. Poultry
5.3. Swine,
5.4. Livestock
5.5. Aquatic animals
5.6. Other animals
6. Type of Drug: Market Size & Analysis
6.1. Overview
6.2. Antibiotic Growth Promoters
6.3. Non-Antibiotics
6.3.1. Prebiotics & Probiotics

6.3.2. Phytogenics
6.3.3. Feed Enzymes
6.3.4. Hormones
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.3. Mergers and Acquisitions, Legal, Awards, Partnerships
8.4. Product Launches and execution
9. Vendor Profiles
9.1. Elanco Animal Health Inc
9.1.1. Overview
9.1.2. Product Offerings
9.1.3. Geographic Revenue
9.1.4. Business Units
9.1.5. Developments
9.1.6. SWOT Analysis
9.1.7. Business Strategy
9.2. Royal DSM N.V
9.2.1. Overview
9.2.2. Product Offerings
9.2.3. Geographic Revenue
9.2.4. Business Units
9.2.5. Developments
9.2.6. SWOT Analysis
9.2.7. Business Strategy
9.3. Cargill, Inc
9.3.1. Overview
9.3.2. Product Offerings
9.3.3. Geographic Revenue
9.3.4. Business Units
9.3.5. Developments

9.3.6. SWOT Analysis
9.3.7. Business Strategy
9.4. Merck & Co., Inc
9.4.1. Overview
9.4.2. Product Offerings
9.4.3. Geographic Revenue
9.4.4. Business Units
9.4.5. Developments
9.4.6. SWOT Analysis
9.4.7. Business Strategy
9.5. Alltech, Inc
9.5.1. Overview
9.5.2. Product Offerings
9.5.3. Geographic Revenue
9.5.4. Business Units
9.5.5. Developments
9.5.6. SWOT Analysis
9.5.7. Business Strategy
9.6. Vetoquinol
9.6.1. Overview
9.6.2. Product Offerings
9.6.3. Geographic Revenue
9.6.4. Business Units
9.6.5. Developments
9.6.6. SWOT Analysis
9.6.7. Business Strategy
9.7. Bupo Animal Health
9.7.1. Overview
9.7.2. Product Offerings
9.7.3. Geographic Revenue
9.7.4. Business Units
9.7.5. Developments
9.7.6. SWOT Analysis
9.7.7. Business Strategy
9.8. Archer-Daniels-Midland Company
9.8.1. Overview
9.8.2. Product Offerings

9.8.3. Geographic Revenue
9.8.4. Business Units
9.8.5. Developments
9.8.6. SWOT Analysis
9.8.7. Business Strategy
9.9. Chr. Hansen
9.9.1. Overview
9.9.2. Product Offerings
9.9.3. Geographic Revenue
9.9.4. Business Units
9.9.5. Developments
9.9.6. SWOT Analysis
9.9.7. Business Strategy
9.10. Novus International, Inc
9.10.1. Overview
9.10.2. Product Offerings
9.10.3. Geographic Revenue
9.10.4. Business Units
9.10.5. Developments
9.10.6. SWOT Analysis
9.10.7. Business Strategy

10. Companies to Watch
10.1. Erber AG
10.1.1. Overview
10.1.2. Market
10.1.3. Business Strategy
10.2. Kemin Industries
10.2.1. Overview
10.2.2. Market
10.2.3. Business Strategy
10.3. Associated British Foods PLC
10.3.1. Overview
10.3.2. Market
10.3.3. Business Strategy
10.4. Nutreco, Erber AG
10.4.1. Overview

10.4.2. Market
10.4.3. Business Strategy
10.5. BASF SE
10.5.1. Overview
10.5.2. Market
10.5.3. Business Strategy
10.6. Phibro Animal Health Corporation
10.6.1. Overview
10.6.2. Market
10.6.3. Business Strategy
10.7. Evonik Industries AG
10.7.1. Overview
10.7.2. Market
10.7.3. Business Strategy
10.8. Bluestar Adisseo Company
10.8.1. Overview
10.8.2. Market
10.8.3. Business Strategy
10.9. Land O'lakes, Inc
10.9.1. Overview
10.9.2. Market
10.9.3. Business Strategy
10.10. Lallemand Inc.
10.10.1. Overview
10.10.2. Market
10.10.3. Business Strategy

11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions

12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations